Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of IBI346#CIBI346Y002#

Clinical trial NCT05266768 · UNKNOWN

Trial details

NCT number: NCT05266768
Sponsor: Chunrui Li
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma

Start date: 2022-04-28
Primary completion: 2024-02-28
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.